Alan Barge
Direktor/Vorstandsmitglied bei THERACRYF PLC
Aktive Positionen von Alan Barge
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
THERACRYF PLC | Direktor/Vorstandsmitglied | 21.10.2015 | - |
Independent Dir/Board Member | 21.10.2015 | - | |
West Thorpe (2011) Ltd. | Direktor/Vorstandsmitglied | - | - |
Oribiotech Ltd.
Oribiotech Ltd. BiotechnologyHealth Technology Oribiotech Ltd. Engages in Cell and Gene Therapy (CGT) manufacturing. The company was founded by Farlan Veraitch and Chris Mason on September 2, 2015 and is headquartered in London, the United Kingdom. | Direktor/Vorstandsmitglied | - | - |
Chief Investment Officer | - | - | |
Delin Ventures Ltd.
Delin Ventures Ltd. Investment ManagersFinance Delin Ventures Ltd. (Delin Ventures) is a venture capital firm founded in 2013 by Igor Linshits. The firm headquartered in London, United Kingdom. | Private Equity Investor | 01.03.2019 | - |
Karriereverlauf von Alan Barge
Ehemalige bekannte Positionen von Alan Barge
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
BERGENBIO ASA | Technik-/Wissenschafts-/F&E-Leiter | 22.11.2018 | 13.03.2019 |
ASTRAZENECA PLC | Corporate Officer/Principal | 01.07.2009 | 01.12.2010 |
AMGEN INC. | Corporate Officer/Principal | 01.06.1990 | 01.09.1998 |
Modra Pharmaceuticals BV
Modra Pharmaceuticals BV Pharmaceuticals: MajorHealth Technology Modra Pharmaceuticals BV designs and develops oral formulations of commonly used anti-cancer drugs. It is a clinical-stage company which develops series of oral formulations of existing IV anticancer drugs which reduce the side effects common to IV formulations, thereby improving patient convenience. The company was founded in June 2010 and is headquartered in Amsterdam, the Netherlands. | Vorsitzender | 19.12.2018 | - |
ASLAN Pharmaceuticals Pte Ltd.
ASLAN Pharmaceuticals Pte Ltd. BiotechnologyHealth Technology ASLAN Pharmaceuticals Pte Ltd. develops novel medicines for global markets. It licenses preclinical and early clinical compounds from global pharmaceutical companies, focusing on oncology, respiratory and inflammation diseases and uses the high quality and efficient development resources available across Asia to progress the drugs through clinical development. The company was founded by Carl Aslan Jason Morton Firth, Mark McHale and Jeffrey Tomlinson in 2010 and is headquartered in Singapore. | Technik-/Wissenschafts-/F&E-Leiter | - | - |
Gründer | 01.01.2016 | - | |
Corporate Officer/Principal | 01.01.2016 | - |
Ausbildung von Alan Barge
University of Oxford | Graduate Degree |
Statistik
International
Vereinigtes Königreich | 7 |
Singapur | 2 |
Vereinigte Staaten | 2 |
Operativ
Corporate Officer/Principal | 3 |
Director/Board Member | 3 |
Chief Tech/Sci/R&D Officer | 2 |
Sektoral
Health Technology | 7 |
Health Services | 2 |
Finance | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 4 |
---|---|
ASTRAZENECA PLC | Health Technology |
AMGEN INC. | Health Technology |
THERACRYF PLC | Health Services |
BERGENBIO ASA | Health Technology |
Private Unternehmen | 5 |
---|---|
ASLAN Pharmaceuticals Pte Ltd.
ASLAN Pharmaceuticals Pte Ltd. BiotechnologyHealth Technology ASLAN Pharmaceuticals Pte Ltd. develops novel medicines for global markets. It licenses preclinical and early clinical compounds from global pharmaceutical companies, focusing on oncology, respiratory and inflammation diseases and uses the high quality and efficient development resources available across Asia to progress the drugs through clinical development. The company was founded by Carl Aslan Jason Morton Firth, Mark McHale and Jeffrey Tomlinson in 2010 and is headquartered in Singapore. | Health Technology |
West Thorpe (2011) Ltd. | |
Modra Pharmaceuticals BV
Modra Pharmaceuticals BV Pharmaceuticals: MajorHealth Technology Modra Pharmaceuticals BV designs and develops oral formulations of commonly used anti-cancer drugs. It is a clinical-stage company which develops series of oral formulations of existing IV anticancer drugs which reduce the side effects common to IV formulations, thereby improving patient convenience. The company was founded in June 2010 and is headquartered in Amsterdam, the Netherlands. | Health Technology |
Oribiotech Ltd.
Oribiotech Ltd. BiotechnologyHealth Technology Oribiotech Ltd. Engages in Cell and Gene Therapy (CGT) manufacturing. The company was founded by Farlan Veraitch and Chris Mason on September 2, 2015 and is headquartered in London, the United Kingdom. | Health Technology |
Delin Ventures Ltd.
Delin Ventures Ltd. Investment ManagersFinance Delin Ventures Ltd. (Delin Ventures) is a venture capital firm founded in 2013 by Igor Linshits. The firm headquartered in London, United Kingdom. | Finance |
- Börse
- Insiders
- Alan Barge
- Erfahrung